Photofrin: payments to doctors
Payments that named Photofrin as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $1.1M
- Providers
- 972
- Transactions
- 3,566
- Average per transaction
- $297
The per-transaction average — $297 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 972 providers the average total is $1,089, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Pinnacle Biologics, Inc | $1,041,584 | 98.4% |
| Concordia Laboratories Inc. | $16,700 | 1.6% |